Vicore Pharma Holding AB
STO:VICO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.32
13.34
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
VICO
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 10 SEK,
Vicore Pharma Holding AB
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Vicore Pharma Holding AB
VICO looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether VICO usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Vicore Pharma Holding AB.
| FR |
|
Pharnext SCA
OTC:PNEXF
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Vicore Pharma Holding AB
Balance Sheet Decomposition
Vicore Pharma Holding AB
| Current Assets | 865.3m |
| Cash & Short-Term Investments | 835.8m |
| Receivables | 6.1m |
| Other Current Assets | 23.3m |
| Non-Current Assets | 1.4m |
| Other Non-Current Assets | 1.4m |
| Current Liabilities | 62.4m |
| Accounts Payable | 14.8m |
| Accrued Liabilities | 40.8m |
| Other Current Liabilities | 6.9m |
| Non-Current Liabilities | 5.6m |
| Other Non-Current Liabilities | 5.6m |
Free Cash Flow Analysis
Vicore Pharma Holding AB
| SEK | |
| Free Cash Flow | SEK |
Earnings Waterfall
Vicore Pharma Holding AB
|
Revenue
|
8.5m
SEK
|
|
Operating Expenses
|
-421.3m
SEK
|
|
Operating Income
|
-412.8m
SEK
|
|
Other Expenses
|
-11.7m
SEK
|
|
Net Income
|
-424.4m
SEK
|
VICO Profitability Score
Profitability Due Diligence
Vicore Pharma Holding AB's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Vicore Pharma Holding AB's profitability score is hidden . The higher the profitability score, the more profitable the company is.
VICO Solvency Score
Solvency Due Diligence
Vicore Pharma Holding AB's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Vicore Pharma Holding AB's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VICO Price Targets Summary
Vicore Pharma Holding AB
According to Wall Street analysts, the average 1-year price target for
VICO
is 24.48 SEK
with a low forecast of 15.15 SEK and a high forecast of 42 SEK.
Dividends
Current shareholder yield for
VICO is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
VICO
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 10 SEK,
Vicore Pharma Holding AB
is
hidden
.